Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

NCT07222748 is registered in ClinicalTrials.gov with TLC Biopharmaceuticals, Inc. as lead sponsor.

NCT NCT07222748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
Lead sponsor
TLC Biopharmaceuticals, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 17, 2025
Completion date
July 31, 2026
Enrollment
304 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain